Joseph Vogel, MBA, is an experienced professional in the biotech and pharmaceutical industries, currently serving as Senior Director of Clinical & Program Leadership at Hemab Therapeutics since July 2023, where the focus is on developing therapeutics for bleeding and thrombotic disorders. Concurrently, Joseph holds the position of Vice President and Board Member at OUTBio since September 2019. Previous roles include Director of Clinical Operations at Intellia Therapeutics, Associate Director of Program Management at Relay Therapeutics, and various leadership positions at Alnylam Pharmaceuticals, Shire, and Outcome. Joseph's extensive background encompasses clinical trial management, program leadership, and operational strategy, complemented by a BA in Psychology from Syracuse University and an MBA from the Isenberg School of Management, UMass Amherst.
This person is not in any offices